UniProt/SwissProt ID: | FCG2A_HUMAN |
Description: | Fc fragment of IgG, low affinity IIa, receptor (CD32) [Source:HGNC Symbol;Acc:3616] |
Location: | chr1 q23.3 |
Node attribute: | substrate |
Phosphorylation site |
Position | PhosphoPeptide | Catalytic kinase | Source |
---|---|---|---|
Y287 | TADGGyMTLNP | SYK | HPRD |
Y288 | TADGGyMTLNP | BLK | phosphoELM; RegPhos |
Y280 | ETNNDyETADG | LYN | HPRD |
Y304 | DDKNIyLTLPP | FYN | RegPhos |
Y288 | TADGGyMTLNP | PhosphoSitePlus; phosphoELM | |
Y281 | ETNNDyETADG | Fyn | phosphoELM; RegPhos |
Y304 | DDKNIyLTLPP | Syk | RegPhos |
Y288 | TADGGyMTLNP | SYK | phosphoELM; RegPhos |
T297 | NPRAPtDDDKN | PhosphoSitePlus | |
Y303 | DDKNIyLTLPP | SYK | HPRD |
Y303 | DDKNIyLTLPP | FYN | HPRD |
Y288 | TADGGyMTLNP | LYN | RegPhos |
Y287 | TADGGyMTLNP | LYN | HPRD |
T290 | DGGYMtLNPRA | PhosphoSitePlus | |
Y240 | VVALIyCRKKR | TM | PhosphoSitePlus |
Y303 | DDKNIyLTLPP | LYN | HPRD |
Y304 | DDKNIyLTLPP | SYK | phosphoELM; RegPhos |
Y288 | TADGGyMTLNP | Syk | RegPhos |
Y281 | ETNNDyETADG | Syk | RegPhos |
T283 | NNDYEtADGGY | PhosphoSitePlus | |
Y281 | ETNNDyETADG | Lyn | phosphoELM; RegPhos |
Y281 | ETNNDyETADG | SYK | phosphoELM; RegPhos |
Y281 | ETNNDyETADG | LYN | RegPhos |
Y304 | DDKNIyLTLPP | PhosphoSitePlus | |
Y304 | DDKNIyLTLPP | Lyn | phosphoELM; RegPhos |
Y304 | DDKNIyLTLPP | BLK | phosphoELM; RegPhos |
Y281 | ETNNDyETADG | FYN | RegPhos |
Y280 | ETNNDyETADG | BLK | HPRD |
Y303 | DDKNIyLTLPP | BLK | HPRD |
Y281 | ETNNDyETADG | BLK | phosphoELM; RegPhos |
Y280 | ETNNDyETADG | SYK | HPRD |
Y304 | DDKNIyLTLPP | LYN | RegPhos |
Y288 | TADGGyMTLNP | Fyn | phosphoELM; RegPhos |
Y288 | TADGGyMTLNP | FYN | RegPhos |
Y281 | ETNNDyETADG | PhosphoSitePlus | |
Y287 | TADGGyMTLNP | BLK | HPRD |
Y304 | DDKNIyLTLPP | Fyn | phosphoELM; RegPhos |
Y287 | TADGGyMTLNP | FYN | HPRD |
T277 | RQLEEtNNDYE | PhosphoSitePlus | |
Y288 | TADGGyMTLNP | Lyn | phosphoELM; RegPhos |
Y280 | ETNNDyETADG | FYN | HPRD |
Dephosphorylation site |
FCG2A_HUMAN do not have dephosphorylation site. |
Mutation site |
Ensembl ID | Variation | Source | Cancer name | Pubmed |
---|---|---|---|---|
ENSP00000271450 | N178K | BIOMART | Breast Cancer | 21930507, 21930502 |
ENSP00000356949 | N177K | BIOMART | Breast Cancer | 21930507, 21930502 |
Differential expressed protein |
FCG2A_HUMAN is not differential expressed protein. |
Hyperphosphorylation site |
FCG2A_HUMAN do not have hyperphosphorylation site. |
Direct Interaction Pair |
Source | Target | Relationship | Resource |
---|---|---|---|
LYN_HUMAN | FCG2A_HUMAN | kinase -> substrate | RegPhos; Robert H Newman (2013) |
KSYK_HUMAN | FCG2A_HUMAN | kinase -> substrate | RegPhos; Robert H Newman (2013) |
FYN_HUMAN | FCG2A_HUMAN | kinase -> substrate | RegPhos; Robert H Newman (2013) |
BLK_HUMAN | FCG2A_HUMAN | kinase -> substrate | RegPhos; Robert H Newman (2013) |
Function Annotation |
KEGG Pathway |
KEGG ID | Pathway |
---|---|
hsa04380 | Osteoclast differentiation |
hsa05322 | Systemic lupus erythematosus |
hsa05140 | Leishmaniasis |
hsa05150 | Staphylococcus aureus infection |
hsa05152 | Tuberculosis |
hsa04145 | Phagosome |
hsa04666 | Fc gamma R-mediated phagocytosis |
Gene Ontology |
GO ID | GO_Term | Evidence | Ontology |
---|---|---|---|
GO:0019864 | IgG binding | IEA | molecular_function |
GO:0005886 | plasma membrane | IEA | cellular_component |
GO:0016021 | integral to membrane | IEA | cellular_component |
GO:0005515 | protein binding | IEA | molecular_function |